MAR 11, 2021 8:00 AM PST

Bye-Bye Burning: A New UTI Vaccine

WRITTEN BY: Tara Fernandez

Researchers have developed a vaccine that “trains” the bladder to fight back against the bacteria that cause urinary tract infections or UTIs. The vaccine is administered directly into the bladder, boosting the weak immune response against bacteria in the urinary tract, which is thought to be a significant contributing factor to UTIs.

UTIs are the most common outpatient infections in the U.S., with as many as 50 percent of women experiencing this painful and disruptive condition in their lifetimes.

According to immunology expert and study lead Soman Abraham, reprogramming the immune system using vaccines can help the body stave off UTI-causing bacteria such as E. coli. The problem is that while this approach shows promise, it has fallen flat in clinical trials, with other vaccines in development demonstrating very little success in keeping UTIs at bay in patients.

“There are currently no effective UTI vaccines available for use in the US in spite of the high prevalence of bladder infections,” Abraham said. “Our study describes the potential for a highly effective bladder vaccine that can not only eradicate residual bladder bacteria, but also prevent future infections.”

Abraham and colleagues tested their new system in a mouse model of UTI, in which they observed that before treatment, very few immune cells were activated to eliminate pathogenic bacteria. This immune phenomenon resulted in the frequent resurgence of infections.

Jianxuan Wu, another investigator for the lab, said: “The new vaccine strategy attempts to ‘teach’ the bladder to more effectively fight off the attacking bacteria.”

“By administering the vaccine directly into the bladder where the residual bacteria harbor, the highly effective vaccine antigen, in combination with an adjuvant known to boost the recruitment of bacterial clearing cells, performed better than traditional intramuscular vaccination.”

These are encouraging findings, said Abraham, who is optimistic about taking the treatment to clinical trials. Indeed, if it proves effective in humans, clinical adoption for the new therapy appears to be a relatively straightforward process, particularly as the individual components of the new vaccine have already been cleared as safe to use by regulatory bodies.

 


Sources: Duke University, PNAS.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 13, 2021
Cancer
Ultrasound Triggers Immunotherapy to Destroy Tumors
AUG 13, 2021
Ultrasound Triggers Immunotherapy to Destroy Tumors
An immunotherapy engineered to be triggered by ultrasound beams significantly slows the growth of cancerous tumors in mi ...
AUG 31, 2021
Clinical & Molecular DX
Five Questions to Help You Select the Best Cellular Stain
AUG 31, 2021
Five Questions to Help You Select the Best Cellular Stain
Cellular stains are organic fluorescent dyes or fluorescent conjugates designed to localize to a specific organelle or c ...
AUG 24, 2021
Immunology
Women Produce More COVID Antibodies Than Men
AUG 24, 2021
Women Produce More COVID Antibodies Than Men
An exploration into the human immune response after a COVID-19 infection has revealed a surprising finding: women produc ...
AUG 23, 2021
Microbiology
During a Chronic Viral Infection, Immune Cells May Suffer 'Exhaustion'
AUG 23, 2021
During a Chronic Viral Infection, Immune Cells May Suffer 'Exhaustion'
Several viruses are known to cause chronic infections, one is hepatitis C virus (HCV). Researchers studying these infect ...
SEP 02, 2021
Immunology
Will an Extra COVID Vaccine Shot Benefit People With Autoimmune Conditions?
SEP 02, 2021
Will an Extra COVID Vaccine Shot Benefit People With Autoimmune Conditions?
The global rollout of COVID-19 vaccines has helped save countless lives during the pandemic. Studies have shown that vac ...
SEP 23, 2021
Immunology
Houses on Mars Held Together With Astronaut Blood?!
SEP 23, 2021
Houses on Mars Held Together With Astronaut Blood?!
A protein abundantly present in the blood plasma of astronauts is perfect for building shelters in outer space, say rese ...
Loading Comments...